×

Products for transfection and reprogramming

  • US 9,127,248 B2
  • Filed: 06/28/2013
  • Issued: 09/08/2015
  • Est. Priority Date: 12/05/2011
  • Status: Active Grant
First Claim
Patent Images

1. A cell-culture medium comprising:

  • DMEM/F12, 10 μ

    g/mL insulin, 5.5 μ

    g/mL transferrin, 6.7 ng/mL sodium selenite, 20 ng/mL bFGF, and 5 mg/mL albumin, wherein the albumin is treated with an ion-exchange resin and/or charcoal.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×